CC
IBB icon

Centiva Capital’s iShares Biotechnology ETF IBB Stock Holding History

Centiva Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,000
Closed -$507K – 2019
2026
Q1 		$507K Buy
+3,000
New +$513K ﹤0.01% 832
2025
Q1 		– Sell
-4,739
Closed -$627K – 1802
2024
Q4 		$627K Buy
+4,739
New +$666K 0.01% 696
2024
Q3 		– Sell
-13,250
Closed -$1.92M – 2358
2024
Q2 		$1.82M Buy
+13,250
New +$1.77M 0.03% 472
2024
Q1 		– Sell
-2,651
Closed -$360K – 1970
2023
Q4 		$360K Buy
+2,651
New +$323K 0.01% 1119
2021
Q1 		– Sell
-74,979
Closed -$11.4M – 1266
2020
Q4 		$11.4M Sell
74,979
-49,991
-40% -$7.14M 0.44% 40
2020
Q3 		$16.9M Buy
124,970
+50,059
+67% +$6.79M 1.11% 9
2020
Q2 		$10.2M Sell
74,911
-88,579
-54% -$11.3M 0.62% 25
2020
Q1 		$17.6M Buy
163,490
+125,165
+327% +$14.4M 0.79% 12
2019
Q4 		$4.62M Buy
38,325
+34,720
+963% +$3.87M 0.23% 94
2019
Q3 		$359K Buy
3,605
+877
+32% +$91.8K 0.02% 399
2019
Q2 		$298K Sell
2,728
-45
-2% -$4.79K 0.02% 302
2019
Q1 		$310K Sell
2,773
-6,819
-71% -$748K 0.02% 260
2018
Q4 		$925K Buy
+9,592
New +$1.02M 0.07% 149

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Centiva Capital's IBB Position: Q2 2026 in Review

Centiva Capital sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 3,000 shares — an estimated $507K sold.

Centiva Capital first reported a position in IBB in Q4 2018 and held it in 13 quarters. The position peaked at $17.6M in Q1 2020. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Centiva Capital reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 3,000 iShares Biotechnology ETF shares in Q2 2026, an estimated $507K.
  • Centiva Capital first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 13 quarters.
  • Centiva Capital's iShares Biotechnology ETF position peaked at $17.6M in Q1 2020.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.